A Bioequivalence Study of TAK-536 Pediatric Formulation

NCT02401464 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Japanese Healthy Adult Males

Interventions

DRUG: TAK-536 Tablet
DRUG: TAK-536 Dry Syrup Formulation
DRUG: TAK-536 Ganule Formulation

Sponsor

Takeda